“HPV16 L2/E6/E7 fusion protein vaccine TA-CIN”的概念、定义、翻译、参考文献-科学参考

A recombinant human papillomavirus (HPV), genetically engineered fusion protein vaccine in which the three HPV16 viral proteins L2, E6 and E7 are fused together in a single tandem fusion protein (TA-CIN; HPV16 L2\\E6\\E7), with potential immunoprotective and antineoplastic properties. Upon administration, HPV16 L2/E6/E7 fusion protein vaccine TA-CIN may stimulate the immune system to generate HPV16 E6\\E7-specific CD4+ and CD8+ T-cell responses as well as the induction of L2-specific antibodies. In addition, this vaccine may prevent infection and the development of other HPV16-associated diseases. L2, a minor viral capsid protein, is able to induce a strong antibody response against certain HPV types.

单词	HPV16 L2/E6/E7 fusion protein vaccine TA-CIN
释义	HPV16 L2/E6/E7 fusion protein vaccine TA-CIN A recombinant human papillomavirus (HPV), genetically engineered fusion protein vaccine in which the three HPV16 viral proteins L2, E6 and E7 are fused together in a single tandem fusion protein (TA-CIN; HPV16 L2\\E6\\E7), with potential immunoprotective and antineoplastic properties. Upon administration, HPV16 L2/E6/E7 fusion protein vaccine TA-CIN may stimulate the immune system to generate HPV16 E6\\E7-specific CD4+ and CD8+ T-cell responses as well as the induction of L2-specific antibodies. In addition, this vaccine may prevent infection and the development of other HPV16-associated diseases. L2, a minor viral capsid protein, is able to induce a strong antibody response against certain HPV types.
随便看	rubitecan rucaparib ruminant ruthenium-based transferrin targeting agent NKP-1339 ruthenium Ru 106 ruxolitinib phosphate rV-TRICOM R(+)XK469 S-1 S100 calcium binding protein A8 S100 calcium binding protein A9 S1P receptor agonist KRP203 S-3304 SAB sabarubicin Saccharomyces boulardii probiotic supplement sacituzumab govitecan sacrum S-adenosyl-L-methionine disulfate p-toluene-sulfonate S-adenosylmethionine safingol sagopilone SAHA Salagen saline